CME/CE

Use the tool below to view all available Omnia Series

Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast Replay
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
0.75 credits
- Kristina Deligiannidis, MD
- Jennifer L. Payne, MD
0.75 credits
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
CME/CE Broadcast Replay
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
1.00 credit
- Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
- Kavita R. Kongara, MD, FACG, FACP
1.00 credit
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
CME/CE Broadcast Replay
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
0.75 credits
- Joseph F. Goldberg, MD
- Roger McIntyre, MD
0.75 credits
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
CME/CE
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
- Melissa Simon, MD
0.50 credits
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
CME/CE
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
0.50 credits
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
MinuteCE®
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
MinuteCE®
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
- Samantha Denäe
1.75 program credits
MinuteCE®
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
1.75 credits 10 episodes
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
- Melissa Simon, MD
- Samantha Denäe
- Casey Joe Hinds
1.75 credits 10 episodes
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
MinuteCE®
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
- Casey Joe Hinds
1.75 program credits
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®
Strategies to Address Healthcare Disparities in Patients With Endometriosis
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
1.75 program credits
Pre- and Postoperative Use of GnRH Antagonists
Pre- and Postoperative Use of GnRH Antagonists
MinuteCE®
Pre- and Postoperative Use of GnRH Antagonists
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
The Integral Role of GnRH Antagonists in the Management of Endometriosis
The Integral Role of GnRH Antagonists in the Management of Endometriosis
MinuteCE®
The Integral Role of GnRH Antagonists in the Management of Endometriosis
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Alloimmune Neutropenia of the Fetus and Newborn
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
- Lee P. Shulman, MD, FACMG, FACOG
- Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
Alloimmune Thrombocytopenia in the Fetus and Newborn
CME/CE
Alloimmune Thrombocytopenia in the Fetus and Newborn
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- James B. Bussel, MD
0.25 credits
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
CME/CE
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD

CME/CE

Popular

Title

Share on ReachMD